title: Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection.
authors.forename: K Y
authors.initials: KY
authors.lastname: Hung
authors.forename: D J
authors.initials: DJ
authors.lastname: Wu
authors.forename: K D
authors.initials: KD
authors.lastname: Wu
authors.forename: W Y
authors.initials: WY
authors.lastname: Chen
authors.forename: T J
authors.initials: TJ
authors.lastname: Tsai
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000097:blood*; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000032:analysis; D019698:Hepatitis C, Chronic / Q000097:blood / Q000628:therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D018937:Hepatitis C Antibodies; D011994:Recombinant Proteins; D004921:Erythropoietin; D005293:Ferritins